Restart Life Sciences Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
| Date | Value | Name | Entity | Role | Shares | Max Price |
|---|---|---|---|---|---|---|
| 08 Nov 24 | Buy€30,928 | Steve Loutskou | Individual | 922,929 | €0.034 | |
| 08 Nov 24 | Buy€15,808 | Derek Lloyd Ivany | Individual | 471,740 | €0.034 | |
| 14 Dec 23 | Buy€1,695 | Derek Lloyd Ivany | Individual | 20,000 | €0.085 |
Insider Trading Volume
Insider Buying: HN3 insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Institutions | 611,300 | 2.06% |
| Individual Insiders | 1,981,469 | 6.68% |
| General Public | 27,070,963 | 91.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 922,929 | €25.4k | 0% | no data | |||
| 711,740 | €19.6k | -42.6% | no data | |||
| 371,300 | €10.2k | 0% | 1.22% | |||
| 346,800 | €9.5k | 189% | no data | |||
| 240,000 | €6.6k | 0% | 100.0% |